These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 30542701)
21. A new generation of monoclonal and recombinant antibodies against cell-adherent prostate specific membrane antigen for diagnostic and therapeutic targeting of prostate cancer. Elsässer-Beile U; Wolf P; Gierschner D; Bühler P; Schultze-Seemann W; Wetterauer U Prostate; 2006 Sep; 66(13):1359-70. PubMed ID: 16894535 [TBL] [Abstract][Full Text] [Related]
22. In vitro and preclinical targeted alpha therapy of human prostate cancer with Bi-213 labeled J591 antibody against the prostate specific membrane antigen. Li Y; Tian Z; Rizvi SM; Bander NH; Allen BJ Prostate Cancer Prostatic Dis; 2002; 5(1):36-46. PubMed ID: 15195129 [TBL] [Abstract][Full Text] [Related]
23. A phase 1 study of a vaccine targeting preferentially expressed antigen in melanoma and prostate-specific membrane antigen in patients with advanced solid tumors. Weber JS; Vogelzang NJ; Ernstoff MS; Goodman OB; Cranmer LD; Marshall JL; Miles S; Rosario D; Diamond DC; Qiu Z; Obrocea M; Bot A J Immunother; 2011 Sep; 34(7):556-67. PubMed ID: 21760528 [TBL] [Abstract][Full Text] [Related]
24. CAR T Cell Therapy in Pancreaticobiliary Cancers: a Focused Review of Clinical Data. Anwar MY; Williams GR; Paluri RK J Gastrointest Cancer; 2021 Mar; 52(1):1-10. PubMed ID: 32700185 [TBL] [Abstract][Full Text] [Related]
25. Prospects for chimeric antigen receptor-modified T cell therapy for solid tumors. Zhang E; Gu J; Xu H Mol Cancer; 2018 Jan; 17(1):7. PubMed ID: 29329591 [TBL] [Abstract][Full Text] [Related]
26. Chimeric antigen receptor T cells: a novel therapy for solid tumors. Yu S; Li A; Liu Q; Li T; Yuan X; Han X; Wu K J Hematol Oncol; 2017 Mar; 10(1):78. PubMed ID: 28356156 [TBL] [Abstract][Full Text] [Related]
27. Enhancement of antitumour immunity by a novel chemotactic antigen DNA vaccine encoding chemokines and multiepitopes of prostate-tumour-associated antigens. Qin H; Zhou C; Wang D; Ma W; Liang X; Lin C; Zhang Y; Zhang S Immunology; 2006 Mar; 117(3):419-30. PubMed ID: 16476062 [TBL] [Abstract][Full Text] [Related]
28. Targeting novel antigens for prostate cancer treatment: focus on prostate-specific membrane antigen. Slovin SF Expert Opin Ther Targets; 2005 Jun; 9(3):561-70. PubMed ID: 15948673 [TBL] [Abstract][Full Text] [Related]
29. The therapeutic potential of a novel PSMA antibody and its IL-2 conjugate in prostate cancer. Sugimoto Y; Hirota M; Yoshikawa K; Sumitomo M; Nakamura K; Ueda R; Niwa R; Suzawa T; Yamasaki M; Shitara K; Kato T; Nakamura K Anticancer Res; 2014 Jan; 34(1):89-97. PubMed ID: 24403448 [TBL] [Abstract][Full Text] [Related]
30. [Advances in prostate-specific membrane antigen targeted therapies for prostate cancer]. Wang W; Mo ZN Zhonghua Nan Ke Xue; 2010 Jun; 16(6):547-51. PubMed ID: 20608362 [TBL] [Abstract][Full Text] [Related]
31. Efficacy studies of an antibody-drug conjugate PSMA-ADC in patient-derived prostate cancer xenografts. DiPippo VA; Olson WC; Nguyen HM; Brown LG; Vessella RL; Corey E Prostate; 2015 Feb; 75(3):303-13. PubMed ID: 25327986 [TBL] [Abstract][Full Text] [Related]
32. Anti-tumor effects and lack of side effects in mice of an immunotoxin directed against human and mouse prostate-specific membrane antigen. Huang X; Bennett M; Thorpe PE Prostate; 2004 Sep; 61(1):1-11. PubMed ID: 15287089 [TBL] [Abstract][Full Text] [Related]
38. Tissue-specificity of prostate specific antigens: comparative analysis of transcript levels in prostate and non-prostatic tissues. Cunha AC; Weigle B; Kiessling A; Bachmann M; Rieber EP Cancer Lett; 2006 May; 236(2):229-38. PubMed ID: 16046056 [TBL] [Abstract][Full Text] [Related]
39. Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells: results of a phase I clinical trial. Fuessel S; Meye A; Schmitz M; Zastrow S; Linné C; Richter K; Löbel B; Hakenberg OW; Hoelig K; Rieber EP; Wirth MP Prostate; 2006 Jun; 66(8):811-21. PubMed ID: 16482569 [TBL] [Abstract][Full Text] [Related]